Found 31 matching trials
A Study to Assess The Relative Bioavailability of New Tablet Formulations of GSK1265744 in Healthy Adult Subjects PHASE1 This study will evaluate two new GSK1265744 sodium salt tablet formulations...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Impact of Long-acting Injectable Cabotegravir for HIV PrEP in MSM in France. PHASE3 The purpose of this study is to evaluate if offering long-acting injectable...
Show More Location
Hôpital Hôtel Dieu
Learn More & Join Trial
Safety, Tolerability and Acceptability of Long-Acting Cabotegravir (CAB LA) for the Prevention of HIV Among Adolescent Males PHASE2 This study will establish the minimum safety, tolerability and acceptabilit...
Show More Location
University of Colorado Denver ATN CRS
Learn More & Join Trial
Efficacy, Safety and Tolerability Study of Long-acting Cabotegravir Plus Long-acting Rilpivirine (CAB LA + RPV LA) in Human-immunodeficiency Virus-1 (HIV-1) Infected Adults PHASE3 This Antiretroviral Therapy as Long Acting Suppression every 2 Months (ATLA...
Show More Status
Active Not Recruiting
Location
GSK Investigational Site
Learn More & Join Trial
A Phase IIb Study to Evaluate a Long-Acting Intramuscular Regimen for Maintenance of Virologic Suppression (Following Induction With an Oral Regimen of GSK1265744 and Abacavir/Lamivudine) in Human Immunodeficiency Virus Type 1 (HIV-1) Infected, Antiretroviral Therapy-Naive Adult Subjects PHASE2 This study is a Phase IIb, randomized, multicentre, parallel group, open-la...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Effect of Rifabutin on the Pharmacokinetics of Oral Cabotegravir in Healthy Subjects PHASE1 This is a Phase I, single-center, open-label, fixed-sequence, 2-period cros...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Safety, Tolerability and Acceptability of Long-Acting Cabotegravir (CAB LA) for the Prevention of HIV Among Adolescent Females PHASE2 This study will establish the minimum safety, tolerability and acceptabilit...
Show More Learn More & Join Trial
Long-Acting Cabotegravir Plus VRC-HIVMAB075-00-AB (VRC07-523LS) for Viral Suppression in Adults Living With HIV-1 PHASE2 The purpose of this study was to assess the safety, tolerability, antiviral...
Show More Learn More & Join Trial
A Study Evaluating Implementation Strategies for the Delivery of APRETUDE for Black cis-and Transgender Women in United States EHE Territories PHASE4 The purpose of the study is to evaluate the appropriateness, adoption, feas...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Study to Identify and Determine Best Implementation Practices for Injectable Cabotegravir+Rilpivirine in the United States (US) PHASE3 Chronic human immunodeficiency virus (HIV) infection in adults continues to...
Show More Location
GSK Investigational Site
Learn More & Join Trial